This article is part of the supplement: Lupus 2012: New targets, new approaches
Lung cancer in systemic lupus erythematosus
1 McGill University Health Centre, Montreal, QC, Canada
2 Northwestern University Feinberg School of Medicine, Chicago, IL, USA
3 Toronto Western Hospital, Toronto, ON, Canada
4 Université de Laval, QC, Canada
5 Johns Hopkins University School of Medicine, Baltimore, MD, USA
6 University of California, San Francisco, CA, USA
7 West Penn Allegheny Health System, Pittsburgh, PA, USA
8 University of Calgary, AB, Canada
9 Lund University Hospital, Lund, Sweden
10 The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea
11 University College, London, UK
12 Dalhousie University and Capital Health, Halifax, NS, Canada
13 College of Medical and Dental Sciences, University of Birmingham, UK
14 Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
15 State University of New York - Downstate Medical Center, Brooklyn, NY, USA
16 Cedars-Sinai Medical Center/David Geffen School of Medicine, University of California Los Angeles, CA, USA
17 The University of Alabama, Birmingham, AL, USA
18 University of North Carolina at Chapel Hill, NC, USA
19 Landspitali University Hospital, Reykjavik, Iceland
20 Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK
21 Université de Montréal, QC, Canada
22 Copenhagen University Hospital, Copenhagen, Denmark
23 Royal University Hospital, Saskatoon, Saskatchewan, Canada
Arthritis Research & Therapy 2012, 14(Suppl 3):A15 doi:10.1186/ar3949
Published: 27 September 2012First paragraph (this article has no abstract)
An increased lung cancer risk in SLE has been suggested in the literature [1]. Our objective was to provide an updated analyses of the lung cancer cases from a multi-site international cohort study, including descriptive statistics of the demographics (age, sex, and race/ethnicity) of cases, as well the of histology.
